NCT03552718 — NantBioScience neoantigen vaccine trial
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
Registry record
| Registry ID | NCT03552718 ↗ |
|---|---|
| Lead sponsor | NantBioScience, Inc. |
| Collaborators | — |
| Phase | Phase 1 |
| Status | Completed |
| Indication | Colorectal Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer, Pancreatic Cancer, Liver Cancer |
| Enrollment | 5 participants |
| Start date | 2018-08-10 |
| Primary completion | 2025-03-18 |
| Last registry update | 7 May 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT03552718), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT03552718?
NCT03552718 (QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.) is registered on ClinicalTrials.gov as Phase 1, sponsored by NantBioScience, Inc..
Is NCT03552718 recruiting?
As of the 2026-05-07 registry update, NCT03552718 is listed as "Completed". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT03552718?
The lead sponsor is NantBioScience, Inc..
What condition does NCT03552718 study?
The registered conditions are Colorectal Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer, Pancreatic Cancer, Liver Cancer. Primary completion is listed as 2025-03-18.
Are results available for NCT03552718?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT03552718.
Back to the full neoantigen vaccine trial tracker — 107 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.